MARCH 27
Days
- :
Hrs
- :
Min
- :
Sec
ePoster Gallery
P348: CHALLENGING PARADIGMS: UTILIZING PANCREATIC CANCER ORGANOIDS TO ADVANCE PERSONALIZED MEDICINE
Nicholas Jette
University of Saskatchewan
P349: CTNNB1 exon 3 hotspot mutations in early-onset hepatocellular carcinoma
Andrew Fleming MD
The University of Tennessee Health Science Center / St. Jude Children's Research Hospital
P350: Chromosome 9p deletions are associated with higher rates of R1 resection across GI cancers
Madeline Silva MD
University of Texas Health San Antonio
P351: Comparison of prediction models for postoperative pancreatic fistula formation after pancreaticoduodenectomy
Pathik Aravind MD
Yale School of Medicine
P352: Degree of Dedifferentiation of Hepatocellular Carcinoma is Not Associated with Decrease Expression of Sphingosine 1-Phosphate Receptor 2
Elizabeth Olecki M.D.
Roswell Park Comprehensive Cancer Center
P353: Developing Reproducible Volume Thresholds for Pancreatectomy using Stratum Specific Likelihood Ratios
Kristen Kaiser
Indiana University
P354: Dual Inhibition of Mitochondrial and Microtubular Function Disrupts Bioenergetics and Cellular Growth in Pancreatic Ductal Adenocarcinoma
Michael Spinrad
P355: Early signs of cardiac impairment in pre-metastatic pancreatic ductal adenocarcinoma
Vignesh Vudatha
VCU Health
P356: Enhancing Survival in Pancreatic Ductal Adenocarcinoma: A Multi-Center Analysis of Adherence to Operative Standards and Guideline-Recommended Therapy
Abdullah Khalid
Northwell Health
P358: Evaluating Synthetic Data Quality: Gaussian and CT-GAN Models in Replicating Clinical Outcomes in Pancreas Cancer Research
Adriana Gamboa MD
MD Anderson Cancer Center
P359: Extracellular vesicles as therapeutic nanoparticles for pancreatic cancer
Shelly Loewenstein
Tel Aviv Sourasky Medical Center
P360: Factors associated with refusal of surgery in Stage I-III Pancreatic Ductal Adenocarcinoma and their effect on survival
Malek Moumne
Medical College of Georgia
P361: Genome-Derived Classification Signature of Pancreatic Acinar Cell Carcinoma Reveals Association with KRAS Wildtype Pancreatic Ductal Adenocarcinoma
Gregory Wasserman DO, PhD
Northwell/Lenox Hill Hospital
P362: Hepatic recurrence rate based on extent of adjuvant floxuridine exposure after resection of colorectal liver metastases
Omar Zaki MD
Memorial Sloan Kettering
P363: Histotripsy for Treatment of Liver Tumors: A Novel Transthoracic Approach
Kristen Kolberg M.D.
P365: Impact of Neoadjuvant Chemotherapy on Operative Outcomes Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma
Leanne Brown
Yale New Haven Health
P366: Inflammatory differences in the tumor microenvironment of diabetic patients with pancreatic ductal adenocarcinoma
Kelly Herremans
University of Florida College of Medicine
P367: Intratumoral lymphangiogenesis does not correlate with outcomes in Hepatocellular Carcinoma
Aeryn Kangas-Dick MD
Roswell Park Comprehensive Cancer Center